𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hyperfractionated Accelerated Radiotherapy for T1,2 Glottic Carcinoma

✍ Scribed by Koh-ichi Sakata; Masanori Someya; Masakazu Hori; Kensei Nakata; Masaru Takagi; Masato Hareyama


Publisher
Springer
Year
2008
Tongue
German
Weight
492 KB
Volume
184
Category
Article
ISSN
0179-7158

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Hyperfractionated and accelerated-hyperf
✍ Carsten Nieder; Ursula Nestle; Ralf Ketter; Harry Kolles; Sascha J. Gentner; Wol πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 139 KB

Because of promising radiobiological advantages allowing dose escalation and/or reduction of treatment time, hyperfractionated and accelerated-hyperfractionated radiotherapy (hf-rt, ahf-rt) were introduced as part of treatment of glioblastoma multiforme (gbm). In December 1988 we started a prospecti

Concurrent hyperfractionated radiotherap
✍ Takayuki Ohguri; Hajime Imada; Keita Nakano; Katsuya Yahara; Tsuyoshi Udaka; Hid πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 162 KB

## Abstract ## Background Our aim was to evaluate the efficacy and toxicity of chemoradiotherapy (CRT) with transoral debulking microsurgery for T2N0 glottic cancer. ## Methods Thirty patients with T2N0 glottic cancer treated with concurrent hyperfractionated radiotherapy (RT) and carboplatin we

Recurrence after radiotherapy for glotti
✍ Laura Viani; P. M. Stell; J. E. Dalby πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 641 KB

A series of 478 patients with T,.,No glottic carcinoma treated by irradiation is presented. Of these patients, 320 were previously untreated, whereas 158 patients were referred for treatment of a recurrence after receiving radiotherapy elsewhere. The primary recurrence rate in the previously untreat

Management of T1–T2 glottic carcinomas
✍ William M. Mendenhall; John W. Werning; Russell W. Hinerman; Robert J. Amdur; Do πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 88 KB

## Abstract T1–T2 glottic carcinomas may be treated with conservative surgery or radiotherapy. The goals of treatment are cure and laryngeal voice preservation. The aim of the current study was to review the pertinent literature and discuss the optimal management of early‐stage laryngeal carcinoma.